Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omnia Bios is an Italian biotechnology company and contract research organization (CRO) based in Siena, specializing in advanced research and development services for the life sciences industry. As a spin-off from the University of Siena and a member of the VisMederi Group, the company provides specialized expertise in microbiology, immunology, and molecular biology. Omnia Bios offers a range of services including Next-Generation Sequencing (NGS), bioinformatics, and the development and validation of diagnostic assays to support vaccine and monoclonal antibody development. The company serves as a strategic partner for pharmaceutical and biotech firms, providing high-quality laboratory testing and bioanalytical support for both pre-clinical and clinical trial phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OMNIABIOS.